biotech
Genomic Tests to Guide Choice of Chemotherapy
Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics by ruth on October 23, 2006
Oncogenomics: Molecular Approaches to Cancer
Scientists at Duke University's Institute for Genome Sciences & Policy have developed a genomic test to help predict which drugs are suitable for treating a patient's cancerous tumor, based on the tumor's genomic profile.
The new tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy, said Anil Potti, M.D., the study's lead investigator and an assistant professor of medicine in the Duke Institute for Genome Sciences & Policy. The tests are designed to help doctors select and initiate treatment with the best drug for a patient's tumor instead of trying various drugs in succession until the right one is found, Potti said.

Preliminary tests indicate that the test is about 80% accurate, and clinical trials are planned for next year. The results of the preliminary study has been published in Nature Medicine (doi:10.1038/nm1491). For an overview, see the press release from Duke University Medical Center.


Permalink: Genomic Tests to Guide Choice of Chemotherapy
Tags: genomics  chemotherapy  cancer  diagnostics  tumor  genetics  biotech  genomic+tests 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/40091
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Genomic Tests to Guide Choice of Chemotherapy:

  • Currently 7.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.33 out of 3 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!